Bill > SB147

This bill expands the prescription authority and professional responsibilities of pharmacists in Alaska by modifying several existing statutes. The bill requires pharmacists seeking initial licensure to receive education in pain management and opioid use and addiction, unless they do not hold a federal Drug Enforcement Administration registration number. For pharmacists seeking licensure through reciprocity from another state, the bill adds the requirement to meet the same pain management and opioid education standards. The legislation also updates continuing education requirements to mandate at least two hours of training in pain management and opioid use and addiction every two years, with potential exemptions for pharmacists whose practice does not involve pain management or opioid prescriptions. Furthermore, the bill clarifies that pharmacists can provide patient care services under a collaborative practice agreement with a non-pharmacist practitioner, which now explicitly includes prescribing and administering drugs or devices, with the important caveat that pharmacists must recognize the limits of their education and training and consult or refer to other practitioners as appropriate. The bill also adds a definition of "opioid" to the existing pharmacy practice statutes and modifies the definition of "practice of pharmacy" to include providing patient care services. The new provisions will take effect on January 1, 2026, giving pharmacists and regulatory bodies time to prepare for the changes.

Budget and Finance, Health and Social Services

https://www.akleg.gov/basis/Bill/Detail/34?Root=SB147